- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00689091
Bispectral Index (BIS) Versus Electronic Alerts in the Prevention of Anesthesia Awareness: the Michigan Awareness Control Study (MACS)
A Prospective, Randomized, Controlled Trial Comparing Bispectral Index Monitoring to Electronic Alerts for Prevention of Awareness During Anesthesia in the General Population
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Electronic alerts have been developed and employed at our institution and have been shown to increase compliance with both clinical and administrative tasks (O'Reilly et al, 2006; Kheterpal et al, 2007). The investigators have developed electronic alerts for the purpose of informing the clinician of potentially insufficient anesthesia based on minimum alveolar concentration (MAC). The algorithm is as follows:
- Every 5 minutes the alerting system checks every active case in our operating rooms. It takes approximately 1 second for this scan of all active cases to occur.
Conditions for an "active case" are:
- data capture is possible (i.e., not a paper record)
- data capture is active (i.e., "patient in room" has been electronically entered and end-tidal [Et] CO2 is detected)
- case has been identified as a general anesthetic
- "anesthesia induction end" has already been documented
- request for recovery room bed or transport to an intensive care unit has not been documented
- surgical dressing completion has not been documented
The alerting system checks the most recent value (within a specified time period) of:
- Et Sevoflurane (MAC=2.0)
- Et Isoflurane (MAC=1.2)
- Et Desflurane (MAC=6)
- Et Nitrous Oxide (MAC=105) and compares it to the MAC of each agent. It adds the resulting MAC values together for "current total MAC."
- The system then checks for a charted propofol infusion in mcg/kg/min and divides by 150, assuming that 150 mcg/kg/min is "1.0 MAC" for propofol. The analogous concept of MAC for propofol is "Cp50"- the plasma or blood concentrations at which 50% of patients do not move in response to a noxious stimulus. Since the investigators do not have the technology at our institution to calculate Cp50 or Cp50-awake, the investigators have chosen the above propofol dose as an initial value based on clinical experience. The resultant MAC equivalent is added to current total MAC.
- The system next checks for a dexmedetomidine infusion with a rate of 0.2 mcg/kg/hour or greater. If present, it multiplies the current total inhalational MAC by 2, as dexmedetomidine can reduce MAC by 50%.
- At this point, the "current total MAC" is defined as: Et Sevo /2 + Et Iso /1.2 + Et Des/6 + Et Nitrous /105 + propofol rate (in mcg/kg/min)/150. If dexmedetomidine is >0.2 mcg/kg/hour, inhalational MAC is multiplied by 2.
- If this total mac < 0.50, it checks to see if a bolus of propofol, midazolam, etomidate, or thiopental has been given in the preceding 10 minutes.
- It alerts the clinician signed into the case within 30-60 seconds if total age-adjusted MAC < 0.50 AND no bolus has been documented in the last 10 minutes.
This will be the protocol in the MAC-guided group. In the BIS-guided group an electronic alert will be sent if the BIS value is >60. If an alert is triggered, the clinician electronically signed into the case receives an alphanumeric page stating "Potentially insufficient anesthesia, please check vaporizers and intravenous lines."
The investigators are collaborating with Washington University, the University of Chicago, and the University of Mannitoba, who will also be testing a MAC-based protocol in comparison to the BIS.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Medical School, University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least 18 years of age, English-speaking, available for follow-up interview at one month.
Exclusion Criteria:
- Pre-existing neurologic or neuropsychiatric condition, surgical manipulation around forehead, not available for follow-up interview.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: BIS group
This group will have BIS values visible and will receive alerts when the value is >60.
|
Comparison of two different alerting protocols.
One using the bispectral index monitor and one using the MAC alerting protocols.
|
Active Comparator: MAC Alert
This group will receive an alert if total MAC (including intravenous infusions) is <0.5 age-adjusted.
|
Comparison of two different alerting protocols.
One using the bispectral index monitor and one using the MAC alerting protocols.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Percentage of Incidences With Explicit Recall in the BIS Versus MAC Alert Groups.
Time Frame: Outcome of awareness is assessed 30-days after the operation
|
By modified intention-to-treat analysis
|
Outcome of awareness is assessed 30-days after the operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Dreams During Anesthesia Compared Between MAC or BIS Monitoring
Time Frame: During surgery (45 minutes - 18 hours), measured based on 30 day interviews
|
Binary variables for whether participants recall dreaming or not.
|
During surgery (45 minutes - 18 hours), measured based on 30 day interviews
|
Percentage of Cases With Electronic Alerts
Time Frame: During surgery: (45 minutes - 18 hours)
|
During surgery: (45 minutes - 18 hours)
|
|
Overall Use of Anesthetics Comparing the BIS to MAC Alerts.
Time Frame: During surgery (45 minutes - 18 hours)
|
During surgery (45 minutes - 18 hours)
|
|
Time Till Discharge Readiness
Time Frame: During recovery room stay: 30 minutes to 6 hours
|
measured in time within Post Anesthesia Care Unit ( PACU) until the participant is ready for discharge from PACU based on a composite of factors, including pain and neurologic status
|
During recovery room stay: 30 minutes to 6 hours
|
Number of Participants Without Nausea or Vomiting
Time Frame: During recovery room stay: 30 minutes to 6 hours
|
During recovery room stay: 30 minutes to 6 hours
|
|
Comparison of the Prospective and Retrospective Approaches to the Study Awareness Incidence.
Time Frame: 30 days after surgery
|
There is controversy regarding the appropriate technique for assessing awareness during anesthesia with explicit recall.
A total cohort was utilized to compare the incidence of awareness with recall as determined by formal interview vs. the incidence of awareness with recall based on spontaneous reports (in the same cohort).
|
30 days after surgery
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Relationship Between BIS Values and Hemodynamic Parameters.
Time Frame: Outcome of hemodynamic stability is assessed
|
Outcome of hemodynamic stability is assessed
|
The Relationship Between Cumulative Deep Hypnotic Time, Anesthetic Doses, and Mortality.
Time Frame: Outcome of mortality is assessed
|
Outcome of mortality is assessed
|
Predictors of Post-traumatic Stress Disorder Based on the Type of Awareness Event.
Time Frame: Outcome of post-traumatic stress disorder is assessed with the covariate of awareness
|
Outcome of post-traumatic stress disorder is assessed with the covariate of awareness
|
Anesthetic Induction Doses, Hypotension, and BIS Values.
Time Frame: Outcome of hypotension in relationship to induction doses and BIS values will be assessed
|
Outcome of hypotension in relationship to induction doses and BIS values will be assessed
|
Meta-Analysis of Awareness Events in Conjunction With the BAG-RECALL Study Based at Washington University.
Time Frame: Outcome of awareness is assessed
|
Outcome of awareness is assessed
|
Incidence of Post-traumatic Stress Disorder.
Time Frame: NEED VALUE HERE
|
NEED VALUE HERE
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: George A. Mashour, M.D., Ph.D., University of Michigan
Publications and helpful links
General Publications
- Vance JL, Shanks AM, Woodrum DT. Intraoperative bispectral index monitoring and time to extubation after cardiac surgery: secondary analysis of a randomized controlled trial. BMC Anesthesiol. 2014 Sep 18;14:79. doi: 10.1186/1471-2253-14-79. eCollection 2014.
- Shanks AM, Avidan MS, Kheterpal S, Tremper KK, Vandervest JC, Cavanaugh JM, Mashour GA. Alerting thresholds for the prevention of intraoperative awareness with explicit recall: a secondary analysis of the Michigan Awareness Control Study. Eur J Anaesthesiol. 2015 May;32(5):346-53. doi: 10.1097/EJA.0000000000000123.
- Avidan MS, Palanca BJ, Glick D, Jacobsohn E, Villafranca A, O'Connor M, Mashour GA; BAG-RECALL Study Group. Protocol for the BAG-RECALL clinical trial: a prospective, multi-center, randomized, controlled trial to determine whether a bispectral index-guided protocol is superior to an anesthesia gas-guided protocol in reducing intraoperative awareness with explicit recall in high risk surgical patients. BMC Anesthesiol. 2009 Nov 30;9:8. doi: 10.1186/1471-2253-9-8.
- Mashour GA, Tremper KK, Avidan MS. Protocol for the "Michigan Awareness Control Study": A prospective, randomized, controlled trial comparing electronic alerts based on bispectral index monitoring or minimum alveolar concentration for the prevention of intraoperative awareness. BMC Anesthesiol. 2009 Nov 5;9:7. doi: 10.1186/1471-2253-9-7.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HUM00013626
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Awareness During General Anesthesia
-
Brugmann University HospitalRecruitingAccidental Awareness During General AnesthesiaBelgium
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedAnesthesia Awareness | Anesthesia; FunctionalTurkey
-
St George's, University of LondonUnknownAwareness, Anesthesia | Obstetric Anesthesia ProblemsUnited Kingdom
-
Baskent University Ankara HospitalUnknownTo Investigate the Incidence and Causes of Awareness During General Anesthesia | To Investigate the of Dreaming During Anesthesia | To Investigate the Intra-operative Experiences of Patients Who Report Awareness | To Investigate the Risk Factors That May be Associated With Awareness | To... and other conditionsTurkey
-
Brno University HospitalMasaryk UniversityRecruiting
-
Dokuz Eylul UniversityCompletedAnesthesia AwarenessTurkey
-
University of Sao PauloRecruiting
-
Assiut UniversityCompletedAwareness, AnesthesiaEgypt
-
Rajiv Gandhi Cancer Institute & Research Center...Completed
-
KVG Medical College and HospitalUnknown
Clinical Trials on Bispectral Index Monitor
-
Bayside HealthCompletedMechanically Ventilated Patients | Intensive Care | Sedated PatientsAustralia
-
Duke UniversityMedtronic - MITG; University of North CarolinaTerminated
-
Centre Hospitalier Universitaire de BesanconUnknown
-
Stryker InstrumentsCompletedAnesthesia, GeneralUnited States
-
Christopher McKeeTerminated
-
Taipei Veterans General Hospital, TaiwanUnknownBispectral Index and Neurmuscular Monitoring Data in Anesthetized PatientsTaiwan
-
Duke UniversityMedtronic - MITGCompletedCritical IllnessUnited States
-
Helsinki University Central HospitalCompleted
-
Hopital FochRecruitingAbdominal SurgeryFrance
-
University Medical Centre LjubljanaCompleted